NEW YORK, July 30 - Zyomyx said today it has pocketed $27 million in a Series E round of private-equity financing.
Investors included existing group Credit Suisse First Boston Private Equity and newcomers Lilly BioVentures and GE Life Science and Technology Finance.
Zyomyx said the cash will go to help ramp up and launch its human cytokine protein-profiling biochip, due in early 2003.